Lundbeck
HLUN-B.CO
#2587
Rank
$5.47 B
Marketcap
$5.74
Share price
-1.88%
Change (1 day)
21.94%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.35

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.35. In 2022 the company made an earnings per share (EPS) of $0.27 a decrease over its 2021 EPS that were of $0.60.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.3531.5%
2022$0.27-55.47%
2021$0.60-51.83%
2020$1.25-28.01%
2019$1.74-44.08%
2018$3.1251.94%
2017$2.05126.64%
2016$0.90-120.84%
2015-$4.345622.18%
2014-$0.07586-110.03%
2013$0.76-28.08%
2012$1.05-52.1%
2011$2.19-1.31%
2010$2.2215.61%
2009$1.92